LifeMD Inc (LFMD)
5.98
-1.02
(-14.51%)
USD |
NASDAQ |
Nov 14, 16:00
5.81
-0.17
(-2.84%)
After-Hours: 20:00
LifeMD Revenue (Quarterly): 50.66M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 50.66M |
| March 31, 2024 | 44.14M |
| December 31, 2023 | 44.86M |
| September 30, 2023 | 38.61M |
| June 30, 2023 | 35.95M |
| March 31, 2023 | 33.13M |
| December 31, 2022 | 28.12M |
| September 30, 2022 | 31.41M |
| June 30, 2022 | 30.46M |
| March 31, 2022 | 29.04M |
| December 31, 2021 | 27.42M |
| September 30, 2021 | 24.95M |
| June 30, 2021 | 22.31M |
| March 31, 2021 | 18.20M |
| December 31, 2020 | 12.89M |
| September 30, 2020 | 11.01M |
| June 30, 2020 | 9.090M |
| March 31, 2020 | 4.305M |
| December 31, 2019 | 3.944M |
| September 30, 2019 | 3.127M |
| June 30, 2019 | 2.698M |
| March 31, 2019 | 2.699M |
| December 31, 2018 | 2.185M |
| September 30, 2018 | 2.038M |
| June 30, 2018 | 2.038M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.606M |
| December 31, 2017 | 0.0982M |
| September 30, 2017 | 2.052M |
| June 30, 2017 | 0.6601M |
| March 31, 2017 | 0.1679M |
| December 31, 2016 | 0.9859M |
| September 30, 2016 | 1.384M |
| June 30, 2016 | 1.227M |
| March 31, 2016 | 1.641M |
| December 31, 2015 | 0.3733M |
| September 30, 2015 | 0.2799M |
| June 30, 2015 | 0.2774M |
| March 31, 2015 | 0.2883M |
| December 31, 2014 | 0.1596M |
| September 30, 2014 | 0.1655M |
| June 30, 2014 | 0.1966M |
| March 31, 2014 | 0.1924M |
| December 31, 2013 | 0.1605M |
| September 30, 2013 | 0.0947M |
| June 30, 2013 | 0.3229M |
| March 31, 2013 | 0.2303M |
| December 31, 2012 | 0.1156M |
| September 30, 2012 | 0.1521M |
| June 30, 2012 | 0.2276M |
| March 31, 2012 | 0.1785M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.944M
Minimum
Dec 2019
50.66M
Maximum
Jun 2024
26.34M
Average
28.12M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| Veradigm Inc | 151.92M |
| TruBridge Inc | 84.73M |
| Streamline Health Solutions Inc | 4.476M |
| LENZ Therapeutics Inc | -- |
| Oruka Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.876M |
| Total Expenses (Quarterly) | 56.97M |
| EPS Diluted (Quarterly) | -0.19 |
| Enterprise Value | 285.85M |
| Gross Profit Margin (Quarterly) | 90.08% |
| Profit Margin (Quarterly) | -13.57% |
| Earnings Yield | -11.71% |
| Normalized Earnings Yield | -11.71 |